That's a question Paul Raeburn raises on the Knight Science Journalism Tracker. Raeburn discusses a story last week in the Gray Lady about the bone-growth product Infuse. The story said a group of spine specialists were charging that "misleading and biased" research was being used to promote the product. Raeburn's criticism: The Times failed to credit a Milwaukee Journal Sentinel reporter who had the story earlier — and better, in his view.
July 5, 2011